Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation - Post Approval Registry

NCT00964392 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT00964392
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00964392 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal Atrial Fibrillation - Post Approval Registry
Lead sponsor
Biosense Webster, Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2009
Completion date
January 5, 2018
Enrollment
437 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation